Filters
Results 1 - 1 of 1
Results 1 - 1 of 1.
Search took: 0.023 seconds
AbstractAbstract
[en] The processing of irradiated MTR-fuels for the production of fission nuclides for nuclear medicine presents a significantly increasing task in the field of chemical separation technology of high activity levels. By far the most required product is MO-99, the mother nuclide of Tc-99m which is used in over 90% of the organ function tests in nuclear medicine. Because of the short half life of Mo-99 (66 h) the separation has to be carried out from shortly cooled neutron irradiated U-targets. The needed product purity, the extremely high radiation level, the presence of fission gases like xenon-133 and of volatile toxic isotopes such as iodine-131 and its compounds in kCi-scale require a sophisticated process technology
Source
Argonne National Lab., IL (United States); 376 p; Jul 1993; p. 313-333; 1992 international meeting on reduced enrichment for research and test reactors; Roskilde (Denmark); 27 Sep - 1 Oct 1992; Also available from OSTI as DE94012405; NTIS
Record Type
Report
Literature Type
Conference
Report Number
Country of publication
ACTINIDE COMPOUNDS, ACTINIDES, BETA DECAY RADIOISOTOPES, BETA-MINUS DECAY RADIOISOTOPES, DAYS LIVING RADIOISOTOPES, ELEMENTS, ENRICHED URANIUM, EVEN-ODD NUCLEI, INTERMEDIATE MASS NUCLEI, ISOTOPE ENRICHED MATERIALS, ISOTOPES, MATERIALS, METALS, MOLYBDENUM ISOTOPES, NUCLEI, RADIOISOTOPES, REACTORS, RESEARCH AND TEST REACTORS, SILICIDES, SILICON COMPOUNDS, TEST FACILITIES, URANIUM, URANIUM COMPOUNDS
Reference NumberReference Number
Related RecordRelated Record
INIS VolumeINIS Volume
INIS IssueINIS Issue